Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
Nnadozie Gabriel C., Founder at TRiBE HQ, shared a post on LinkedIn:
“Hemophilia: When The Blood Struggles to Clot
What happens when a small cut refuses to stop bleeding?
For someone living with hemophilia, the problem is not that they have too much blood.
Their blood is missing or has very low levels of an important clotting factor needed to stop bleeding properly.
There are two common types:
- Hemophilia A: Factor VIII is low or missing.
- Hemophilia B: Factor IX is low or missing.
These factors help the body form a strong blood clot.
Without enough of them, bleeding can last longer than normal and may sometimes occur internally, especially in the joints and muscles.
Why does it mostly affect males?
Hemophilia A and B are usually X-linked inherited conditions. This means the faulty gene is carried on the X chromosome.
Because males have only one X chromosome, inheriting the faulty gene can result in hemophilia.
Females have two X chromosomes and are more commonly carriers, although females can also have hemophilia in certain circumstances.
Can hemophilia be treated?
Yes.
There is currently no simple permanent cure for most inherited cases, but effective treatments can greatly reduce bleeding and help people live active lives.
Treatment can include:
- Clotting-factor replacement: replacing the missing Factor VIII or IX.
- Other medicines: some treatments help the body produce or maintain clotting activity.
- Gene therapy: for some eligible patients, gene therapy can provide a functional copy of the affected gene and potentially reduce the need for regular factor treatment. However, eligibility, availability, cost, and long-term outcomes remain important considerations.
What can we do?
Hemophilia is not simply a medical issue. It is also an issue of awareness, access, and affordability.
We need:
- Earlier diagnosis
- Better access to treatment
- Affordable clotting-factor therapy
- Genetic counselling for affected families
- Greater public awareness
- Stronger healthcare systems and specialist care
Most importantly, people living with hemophilia should not be defined by their condition.
With appropriate care, they can learn, work, study, build families, pursue their ambitions, and live productive lives.
Understanding the condition is the first step.
Access to proper care is the next.
As future healthcare professionals and members of society, we can help turn knowledge into better outcomes.
Repost if you value healthcare and awareness, someone might need this information right now.
Let’s learn, educate, advocate and save lives…”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA
-
Nov 20, 2026, 06:44Ann Van De Velde: Emerging Advances in Hemoglobinopathies, Sickle Cell Disease and Rare Anemias